The abstract is read at the publisher; the summary is JClub's.
Reversible covalent modulators that target non-cysteine nucleophiles—especially serine and lysine—are emerging as a promising way to modulate protein-protein interactions with sustained engagement and selectivity.
- Why it matters: Protein-protein interactions are key therapeutic targets, but many interfaces are hard to drug; reversible covalent strategies aim to address limited residence time and difficult binding-site properties.
- What they did: This review surveys emerging reversible electrophile–nucleophile chemistries beyond cysteine, emphasizing serine and lysine, and discusses PPI case studies illustrating these non-cysteine approaches.
- The result: The evidence summarized supports a growing repertoire of reversible covalent chemistries beyond cysteine-based strategies, potentially expanding options for PPI modulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.